What the six lenses say about JUBLPHARMA — its relative strength vs the baselines, price & RS trend, the 8-quarter financials, and live filings.
How JUBLPHARMA’s own sector index is moving — context for reading the stock’s six lenses.
Six-lens read
The actual numbers
The actual numbers
Full 8-quarter history in the financials table below.
The actual numbers
The actual numbers
Every filing in the corporate-announcements panel below.
The actual numbers
Decile — each lens’s 0–100 score is ranked against every Small-cap stock in the universe. D10 = top 10% (strongest), D1 = bottom 10%. A decile is simply where this stock sits versus its size-peers on that lens — no weighting, no black box.
Conviction — the average of the two active conviction-lens deciles (Technical & Flow):
Fundamental, Catalyst, Valuation and Policy are shown for context but carry weight 0 in the current model, so they are not scored into conviction. Full detail on the methodology page ↗.
Glass box
Click a lens to expand its sub-components, then drill to the actual values. The eye icon on any term explains it.
Policy
Active policies relevant to this sector — flagged as a Red / Amber / Green signal, not scored into the six-lens conviction. The lenses say what the market is doing; policy is context for why.
PLI Scheme — Pharmaceuticals & API
Production-linked incentive scheme for pharmaceuticals, APIs, and medical devices
Percentage-point spread vs each baseline across six windows. Green = outperforming, red = lagging. Data as of 2026-09-08.
| Baseline | 1D | 1W | 1M | 3M | 6M | 12M |
|---|---|---|---|---|---|---|
Nifty 50 Large-cap anchor | +3.3pp | +9.0pp | +6.1pp | -3.6pp | +18.9pp | -10.1pp |
Nifty 500 Broad-market baseline | +3.2pp | +9.0pp | +5.0pp | -5.2pp | +13.2pp | -15.3pp |
Sector Own-sector index | — | — | +2.2pp | -11.2pp | +0.0pp | -36.1pp |
From atlas_foundation.technical_daily. Sector row covers 1M–12M (1D/1W not stored).
Trend
JUBLPHARMA daily close with the three trend EMAs · atlas_foundation.ohlcv_stock.
Relative strength
JUBLPHARMA ÷ Nifty 500, rebased to 100 at window start — above 100 = outperforming since then.
TradingView composite technical analysis — multi-timeframe consensus
Last 8 quarters from the company’s filings (₹ crore) — revenue, profit, margins and the growth trend.
| Metric | Jun '24 | Sep '24 | Dec '24 | Mar '25 | Jun '25 | Sep '25 | Dec '25 | Mar '26 |
|---|---|---|---|---|---|---|---|---|
| Revenue (₹cr) | 1,732 | 1,752 | 1,822 | 1,929 | 1,901 | 1,966 | 2,122 | 2,290 |
| ↳ change QoQ | — | +1.2% | +4.0% | +5.9% | -1.5% | +3.4% | +7.9% | +7.9% |
| EBITDA (₹cr) | 661 | 297 | 278 | 345 | 290 | 341 | 289 | 339 |
| EBITDA margin | 38.2% | 16.9% | 15.2% | 17.9% | 15.3% | 17.3% | 13.6% | 14.8% |
| PAT (₹cr) | 482 | 103 | 101 | 151 | 102 | 120 | 56 | 119 |
| ↳ change QoQ | — | -78.7% | -1.8% | +50.0% | -32.5% | +17.6% | -53.3% | +112.5% |
| Net margin | 27.8% | 5.9% | 5.5% | 7.8% | 5.4% | 6.1% | 2.6% | 5.2% |
| EPS (₹) | 30.44 | 6.47 | 6.37 | 9.64 | 6.46 | 7.55 | 3.51 | 7.50 |
| D/E | — | — | — | — | — | — | — | — |
Filings to the exchange — capital actions, earnings and governance. Most recent first.
A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗An exchange filing — open the original disclosure on NSE for the full text.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗A governance / disclosure filing — lower signal weight, context only.
View original filing on NSE ↗…and 5 more.
Ownership
Mutual funds holding JUBLPHARMA (10)
| Fund | Weight | AUM ₹cr | Grade |
|---|---|---|---|
| Quant Small Cap Gr | 0.81% | 34,069 | |
| Bandhan Small Cap Reg Gr | 1.20% | 31,103 | |
| Kotak Multicap Reg Gr | 0.60% | 29,274 | |
| Aditya BSL Small Cap Gr | 0.80% | 5,865 | |
| HDFC Pharma and Healthcare Reg Gr | 1.01% | 2,940 | |
| Abakkus Small Cap Reg Gr | 1.46% | 2,113 | |
| Kotak Consumption Reg Gr | 1.50% | 1,759 | |
| Tata India Pharma & Healthcare Reg Gr | 0.83% | 1,541 | |
| UTI Healthcare Reg Gr | 0.61% | 1,371 | |
| Aditya BSL Pharma & Hlthcare Reg Gr | 0.55% | 1,074 |
ETFs holding JUBLPHARMA (1)
| ETF | Weight | Grade |
|---|---|---|
| Mirae Asset Nifty 500 Healthcare ETF | 0.54% |